Clearmind Medicine Inc. - Common Shares, no par value per share (CMND)

CUSIP: 185053402

Q3 2024 13F Holders as of 30 Sep 2024

Holder snapshot 6 signals
Share change
+536,623
SEC-reported price per share
$1.22
Indexed holders
8
Value change
+$5,284,113
Number of buys
6
Number of sells
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
2,174,400

Security key

185053402

Report period

Q3 2024

Indexed institutions

8

Top holders

7

Ownership snapshot

Top reported holders of CMND - Clearmind Medicine Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
AdvisorShares Investments...
Disclosed value leader
AdvisorShares Investments...
Comparable rows
0/4
Latest evidence
30 Jun 2024
13F Highest disclosed value: $213,544 4 rows are not safely comparable across share classes.

Quick read

AdvisorShares Investments LLC has the largest disclosed position value at $213.5K.

0 of 4 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens AdvisorShares Investments LLC's linked filing trail.
Disclosed position value Top 4
AdvisorShares Investments LLC $213.5K
Cornerstone Wealth Group, LLC $33.6K
GEODE CAPITAL MANAGEMENT, LLC $27.9K
ROYAL BANK OF CANADA $1K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-4 of 4 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
AdvisorShares Investments LLC
13F
Company
13F
—
denominator unverified
$213,544
128,641 shares
— 30 Jun 2024
Cornerstone Wealth Group, LLC
13F
Company
13F
—
denominator unverified
$33,600
20,000 shares
— 30 Jun 2024
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$27,864
16,586 shares
— 30 Jun 2024
ROYAL BANK OF CANADA
13F
Company
13F
—
denominator unverified
$1,000
569 shares
— 30 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
8
Shares
702,419
Indexed holders
8
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 indexed holders
4
Q3 2024 indexed holders
8
Indexed holder difference
4
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 value Q3 2024 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .